Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: A randomized controlled trial

Diabetes Research and Clinical Practice

Volumn 105, Issue 3, 2014, Pages 327-335

  Taveira, Tracey H ^a,b,c   Wu, Wen Chih ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Blood pressure; Diabetes; Hemoglobin A1c; Randomized controlled trial

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; TREATMENT OUTCOME; AFTERCARE; AMBULATORY CARE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETIC CARDIOMYOPATHIES; MIDDLE AGED; PATIENT EDUCATION; PROCEDURES; RISK REDUCTION;

AFTERCARE; AGED; AMBULATORY CARE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETIC CARDIOMYOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; RISK REDUCTION BEHAVIOR;

EID: 84921637548     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.05.013     Document Type: Article

References (34)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853. UKPDS Study Group.
2. Centers for Disease Control National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011, Centers for Disease Control, Atlanta, GA. Centers for Disease Control (Ed.).
3. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209. 10.1161/CIR.0b013e3182009701.
4. Gaede P., Vedel P., Larsen N., Jensen G.V.H., Parving H.-H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348(5):383-393.
5. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589.
6. Ray K.K., Seshasai S.R.K., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373(9677):1765-1772.
7. Wu H., Xu M.-J., Zou D.-J., Han Q.-J., Hu X. Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Chin Med J 2010, 123(20):2908-2913.
8. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults.
9. Standards of Medical Care in Diabetes - 2006. Diabetes Care 2006, 29(S1):S4-S42. American Diabetes Association.
10. Chobanian A., Bakris G., Cushman W., Green L., Izzo J.L., Jones D.W., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) NHLBI. Hypertension 2003, (42):1206-1252.
11. Taveira T.H., Wu W.C., Martin O.J., Schleinitz M., Friedman P., Sharma S. Pharmacist-led cardiac risk reduction model. Prev Cardiol 2006, 9(4):202-208.
12. Pirraglia P., Taveira T.H., Cohen L., Wu W. Effectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depression. Prev Chronic Dis 2008, 5(4):1-7.
13. Taveira T.H., Friedmann P.D., Cohen L.B., Dooley A.G., Khatana S.A.M., Pirraglia P.A., et al. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ 2010, 36(1):109-117.
14. Cohen L.B., Taveira T.H., Khatana S.A., Dooley A.G., Pirraglia P.A., Wu W.C. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011, 37(November (6)):801-812.
15. Edelman D., Fredrickson S.K., Melnyk S.D., Coffman C.J., Jeffreys A.S., Datta S., et al. Medical clinics versus usual care for patients with both diabetes and hypertension. Ann Intern Med 2010, 152(11):689-696.
16. Mensing C., Boucher J., Cypress M., Weinger K., Mulcahy K., Barta P., et al. National standards for diabetes self-management education. Diabetes Care 2006, 29(90001):S78-S85.
17. Willett W.C., Howe G.R., Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997, 65(4 Suppl.):1220S-1228S. discussion 1229S-1231S.
18. Rollnick S., Mason P., Butler C. Health behavior change: a guide for practitioners 1999, Churchill Livingstone, New York.
19. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care 2013, 36(Suppl. 1):S11-S66.
20. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317:703-713.
21. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412.
22. Kim J.W., Bosworth H.B., Voils C.I., Olsen M., Dudley T., Gribbin M., et al. How well do clinic-based blood pressure measurements agree with the mercury standard?. J Gen Intern Med 2005, 20(7):647-649.
23. National Cholesterol Education Program Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) 2004, NHLBI, Available from: http://hin.nhlbi.nih.gov/cvd_frameset.htm [cited 06.07.05].
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
25. Bittner V., Olson M., Kelsey S.F., Rogers W.J., Bairey Merz C.N., Armstrong K., et al. Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. Am J Cardiol. 2000, 85(9):1083-1088.
26. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982, 69:239-241.
27. Bodenheimer T., Pham H. Primary care: current problems and proposed solutions. Healh Aff (Millwood) 2010, 29:799-805.
28. Massachusetts Medical Society Access to health care in Massachusetts: the implication of health care reform 2011.
29. Cohen L.B., Taveira T.H., Wu W.C., Pirraglia P.A. Maintenance of risk factor control in diabetic patients with and without mental health conditions after discharge from a cardiovascular risk reduction clinic. Ann Pharmacother 2010, 44(7-8):1164-1170.
30. Edelman D.A., Department of Veterans Affairs, Health Services Research and Development Service, Durham VA Medical Center Evidence-based Synthesis Program Center. Shared medical appointments for chronic medical conditions a systematic review 2012, Dept. of Veterans Affairs, Washington, DC, Available from: http://www.ncbi.nlm.nih.gov/books/NBK99785/.
31. Taveira T.H., Pirraglia P., Cohen L., WC W. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Prev Cardiol 2007, 11(4):195-200.
32. Noffsinger E. Increasing quality care and access while reducing cost through drop-in group medical appointments (DIGMAs). Group Pract J 1999, 48(1):12-18.
33. Housden L., Wong S.T., Dawes M. Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis. CMAJ 2013, 185(13).
34. Riley S.B., Marshall E.S. Group visits in diabetes care: a systematic review. Diabetes Educ 2010, 36(6):936-944.